NGL Fine-Chem Ltd

NGLFINE

Company Profile

  • Business description

    NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.

  • Contact

    301, E Square, Subhash Road
    Vile Parle (East)
    MumbaiMH400057
    IND

    T: +91 2240842222

    https://www.nglfinechem.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2026

    Employees

    523

Stocks News & Analysis

stocks

ASX listed software provider joins global sell-off

Our thesis remains unchanged.
stocks

AMD earnings: Data center demand still looks quite strong to us

AMD has the components to target $100 billion of AI revenue in the next few years.
stocks

PayPal earnings: Growth slows, new CEO appointed

We expect to lower our fair value estimate of PayPal stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,175.505.40-0.06%
CAC 408,262.1682.661.01%
DAX 4024,603.04177.75-0.72%
Dow JONES (US)49,501.30260.310.53%
FTSE 10010,402.3487.750.85%
HKSE26,847.3212.550.05%
NASDAQ22,904.58350.61-1.51%
Nikkei 22554,133.71159.65-0.29%
NZX 50 Index13,485.8418.550.14%
S&P 5006,882.7235.09-0.51%
S&P/ASX 2008,903.600.40-0.00%
SSE Composite Index4,102.2034.460.85%

Market Movers